stockrow
Friday 6 November 2026
Export BKYI’s income statement to Excel — free account
BIO-key International Inc.
BKYI Industrials Security & Protection Services
BIO-key International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 million, down 14.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +72.0%
- Free cash flow
- +4.04%
- Total debt
- −90.1%
Quarter to June 2026, against a year earlier
2.48
0.11
+4.64%
Follow BKYI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 3 | 4 |
+8 more TTM periods Free account |
| (107.91%) | (106.71%) | (161.24%) | (137.69%) | ||
| (67.07%) | (68.52%) | (84.61%) | (51.51%) | ||
ROIC |
(121.93%) | (149.28%) | (173.28%) | (47.66%) | |
Return on Tangible Assets |
(728.80%) | (491.39%) | (474.25%) | (492.04%) | |
Average Days of Receivables |
94.34 | 88.69 | 75.05 | 55.45 | |
Free Cash Flow per Share |
(4.01) | (4.05) | (7.04) | (5.09) | |
Free Cash Flow |
(4.16) | (4.19) | (4.68) | (3.35) | |
Capital Expenditures |
— | — | (0.01) | 0.00 | |
| Other line items | |||||
Cash ROIC |
(72.59%) | (58.60%) | (59.61%) | (36.52%) | |
Accounts Receivable Turnover |
4.67 | 5.36 | 5.90 | 12.53 | |
Accounts Payable Turnover |
1.93 | 2.71 | 2.07 | 1.23 | |
Inventory Turnover |
3.61 | 4.22 | 3.67 | 3.49 | |
Average Days of Payables |
119.91 | 127.68 | 134.88 | 175.42 | |
Days of Inventory on Hand |
109.56 | 84.03 | 98.59 | 105.48 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
39.34% | 40.63% | 43.96% | 40.78% | |
Selling, General and Administrative Expense of Revenue |
91.09% | 96.05% | 105.81% | 99.12% | |
Share Based Compensation of Revenue |
2.32% | 2.25% | 2.81% | 3.13% | |
Interest Coverage |
(108.23) | (121.78) | (112.30) | (27.43) | |
Operating CF/Net income |
0.69 | 0.63 | 0.65 | 0.79 | |
Depreciation/Fixed assets |
19.15 | 13.94 | 11.98 | 10.56 | |
Capex/Depreciation |
0.00 | 0.00 | (0.01) | 0.00 | |
Revenue per Share |
6.46 | 6.26 | 8.93 | 9.59 | |
Operating CF per Share |
(4.01) | (4.05) | (7.02) | (5.09) | |
Capex per Share |
0.00 | 0.00 | (0.02) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026